SOLESENCE INC (SLSN) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:SLSN • US6300791018

1.48 USD
+0.13 (+9.63%)
At close: Feb 2, 2026
1.48 USD
0 (0%)
After Hours: 2/2/2026, 8:00:03 PM
Fundamental Rating

2

Overall SLSN gets a fundamental rating of 2 out of 10. We evaluated SLSN against 83 industry peers in the Chemicals industry. SLSN has a medium profitability rating, but doesn't score so well on its financial health evaluation. While showing a medium growth rate, SLSN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • SLSN had positive earnings in the past year.
  • SLSN had a negative operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: SLSN reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: SLSN reported negative operating cash flow in multiple years.
SLSN Yearly Net Income VS EBIT VS OCF VS FCFSLSN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 1.98%, SLSN is in the better half of the industry, outperforming 63.86% of the companies in the same industry.
  • With a decent Return On Equity value of 6.21%, SLSN is doing good in the industry, outperforming 67.47% of the companies in the same industry.
  • SLSN has a Return On Invested Capital of 2.22%. This is in the lower half of the industry: SLSN underperforms 65.06% of its industry peers.
Industry RankSector Rank
ROA 1.98%
ROE 6.21%
ROIC 2.22%
ROA(3y)-4.23%
ROA(5y)0.56%
ROE(3y)-82.95%
ROE(5y)-36.3%
ROIC(3y)N/A
ROIC(5y)N/A
SLSN Yearly ROA, ROE, ROICSLSN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

  • Looking at the Profit Margin, with a value of 1.72%, SLSN is in line with its industry, outperforming 59.04% of the companies in the same industry.
  • In the last couple of years the Profit Margin of SLSN has remained more or less at the same level.
  • SLSN has a Operating Margin of 1.87%. This is in the lower half of the industry: SLSN underperforms 72.29% of its industry peers.
  • In the last couple of years the Operating Margin of SLSN has grown nicely.
  • Looking at the Gross Margin, with a value of 24.77%, SLSN is in line with its industry, outperforming 44.58% of the companies in the same industry.
  • SLSN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.87%
PM (TTM) 1.72%
GM 24.77%
OM growth 3Y4.13%
OM growth 5YN/A
PM growth 3Y0.93%
PM growth 5YN/A
GM growth 3Y1.61%
GM growth 5Y8.11%
SLSN Yearly Profit, Operating, Gross MarginsSLSN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 30

More info and screens

1

2. Health

2.1 Basic Checks

  • SLSN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • SLSN has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, SLSN has more shares outstanding
  • SLSN has a better debt/assets ratio than last year.
SLSN Yearly Shares OutstandingSLSN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
SLSN Yearly Total Debt VS Total AssetsSLSN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

  • SLSN has an Altman-Z score of 0.70. This is a bad value and indicates that SLSN is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.70, SLSN is doing worse than 78.31% of the companies in the same industry.
  • A Debt/Equity ratio of 0.92 indicates that SLSN is somewhat dependend on debt financing.
  • SLSN has a worse Debt to Equity ratio (0.92) than 63.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF N/A
Altman-Z 0.7
ROIC/WACC0.15
WACC15.19%
SLSN Yearly LT Debt VS Equity VS FCFSLSN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

2.3 Liquidity

  • A Current Ratio of 1.84 indicates that SLSN should not have too much problems paying its short term obligations.
  • SLSN has a Current ratio (1.84) which is comparable to the rest of the industry.
  • A Quick Ratio of 0.78 indicates that SLSN may have some problems paying its short term obligations.
  • SLSN's Quick ratio of 0.78 is on the low side compared to the rest of the industry. SLSN is outperformed by 83.13% of its industry peers.
Industry RankSector Rank
Current Ratio 1.84
Quick Ratio 0.78
SLSN Yearly Current Assets VS Current LiabilitesSLSN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

4

3. Growth

3.1 Past

  • The earnings per share for SLSN have decreased strongly by -50.00% in the last year.
  • SLSN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.20% yearly.
  • SLSN shows a strong growth in Revenue. In the last year, the Revenue has grown by 30.04%.
  • SLSN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 33.15% yearly.
EPS 1Y (TTM)-50%
EPS 3Y9.2%
EPS 5YN/A
EPS Q2Q%-150%
Revenue 1Y (TTM)30.04%
Revenue growth 3Y21.09%
Revenue growth 5Y33.15%
Sales Q2Q%-13.46%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SLSN Yearly Revenue VS EstimatesSLSN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
SLSN Yearly EPS VS EstimatesSLSN Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 0 0.02 -0.02 0.04 -0.04 -0.06

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 148.00, which means the current valuation is very expensive for SLSN.
  • Based on the Price/Earnings ratio, SLSN is valued a bit more expensive than the industry average as 65.06% of the companies are valued more cheaply.
  • SLSN's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.41.
Industry RankSector Rank
PE 148
Fwd PE N/A
SLSN Price Earnings VS Forward Price EarningsSLSN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • SLSN's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. SLSN is more expensive than 85.54% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 55.41
SLSN Per share dataSLSN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

  • SLSN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

SOLESENCE INC

NASDAQ:SLSN (2/2/2026, 8:00:03 PM)

After market: 1.48 0 (0%)

1.48

+0.13 (+9.63%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-11
Earnings (Next)03-24
Inst Owners5.71%
Inst Owner ChangeN/A
Ins Owners26.62%
Ins Owner Change0.11%
Market Cap104.40M
Revenue(TTM)62.15M
Net Income(TTM)1.07M
AnalystsN/A
Price TargetN/A
Short Float %3.98%
Short Ratio16.79
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 148
Fwd PE N/A
P/S 1.68
P/FCF N/A
P/OCF N/A
P/B 6.06
P/tB 6.06
EV/EBITDA 55.41
EPS(TTM)0.01
EY0.68%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)-0.12
OCFYN/A
SpS0.88
BVpS0.24
TBVpS0.24
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.23
Profitability
Industry RankSector Rank
ROA 1.98%
ROE 6.21%
ROCE 3.22%
ROIC 2.22%
ROICexc 2.24%
ROICexgc 2.24%
OM 1.87%
PM (TTM) 1.72%
GM 24.77%
FCFM N/A
ROA(3y)-4.23%
ROA(5y)0.56%
ROE(3y)-82.95%
ROE(5y)-36.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y17.57%
ROICexgc growth 5YN/A
ROICexc growth 3Y17.57%
ROICexc growth 5YN/A
OM growth 3Y4.13%
OM growth 5YN/A
PM growth 3Y0.93%
PM growth 5YN/A
GM growth 3Y1.61%
GM growth 5Y8.11%
F-Score3
Asset Turnover1.15
Health
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF N/A
Debt/EBITDA 7.66
Cap/Depr 474.12%
Cap/Sales 6.9%
Interest Coverage 1.43
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.84
Quick Ratio 0.78
Altman-Z 0.7
F-Score3
WACC15.19%
ROIC/WACC0.15
Cap/Depr(3y)375.85%
Cap/Depr(5y)357.51%
Cap/Sales(3y)6.36%
Cap/Sales(5y)6.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-50%
EPS 3Y9.2%
EPS 5YN/A
EPS Q2Q%-150%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)30.04%
Revenue growth 3Y21.09%
Revenue growth 5Y33.15%
Sales Q2Q%-13.46%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-66.41%
EBIT growth 3Y26.09%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2511.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-688.02%
OCF growth 3Y-5.29%
OCF growth 5YN/A

SOLESENCE INC / SLSN FAQ

What is the ChartMill fundamental rating of SOLESENCE INC (SLSN) stock?

ChartMill assigns a fundamental rating of 2 / 10 to SLSN.


Can you provide the valuation status for SOLESENCE INC?

ChartMill assigns a valuation rating of 0 / 10 to SOLESENCE INC (SLSN). This can be considered as Overvalued.


What is the profitability of SLSN stock?

SOLESENCE INC (SLSN) has a profitability rating of 4 / 10.